TRANSFORMS was a 1-year, randomized, double blind, double-dummy phase 3 trial which compared the effect of 0
TRANSFORMS was a 1-year, randomized, double blind, double-dummy phase 3 trial which compared the effect of 0.5 mg and 1.25 mg doses of fingolimod to the effect of weekly intramuscular…